Active, not recruiting
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines
NCT05976243
- Conditions
- Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +11 more
- Locations
-
- Allervie Clinical Research Birmingham, Alabama, United States
- Acuro Research Inc Little Rock, Arkansas, United States
- Kern Research Bakersfield, California, United States
- Allergy and Asthma Specialists Group Huntington Beach, California, United States